CAR T Therapy Is Becoming More Decentralized and Patient Centered – City of Hope
City of Hope shared a post on LinkedIn:
“The delivery of cell therapies is evolving faster than many realize.
CAR T and other cellular treatments are expected to become more decentralized in 2026, with care shifting into outpatient clinics and select home-based settings.
This transition, supported by remote monitoring and digital health, has the potential to significantly reduce hospital stays, lower overall costs and expand access to complex cancer therapies.
Eileen Smith, M.D., the Francis and Kathleen McNamara Distinguished Chair and Professor, Department of Hematology and Hematopoietic Cell Transplantation, outlines how City of Hope‘s model, developing cell therapies on site and delivering care beyond inpatient settings, is helping set a new national standard for patient-centered treatment.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
May 16, 2026, 16:50Amanda Lund on Lymphatic Vessels as Body’s Defense in Cancer – NYU Langone Health
-
May 16, 2026, 16:36Deep Vein Thrombosis Month with Mark Goldin and Timothy Wu – Northwell Health
-
May 16, 2026, 16:27Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
-
May 16, 2026, 16:26Tagreed Alkaltham: Why Can Some Apheresis Donors Donate More Frequently?
-
May 16, 2026, 16:26Living with Hemophilia Looks Very Different Today Than It Did Decades Ago – UNC Health
-
May 16, 2026, 16:23Scientific Excellence and Clinical Innovationat the 2026 Hadassah Hematology Conference – RFHMO
-
May 16, 2026, 16:22Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
-
May 16, 2026, 16:20Abdallah Othman: Exploring the Detailed Diagram of the Coronary Arteries
-
May 16, 2026, 16:16The Minute That Saved a Life – Elle’s Battle with a Dismissed Blood Clot – National Blood Clot Alliance